Stacy Kearney Bucha, General ManagerDriven to serve its 65,000+ customers across various segments of healthcare, the company utilizes unmatched clinical expertise and operational excellence to keep communities across the country healthy through vaccination.
“We’re a services and solutions company dedicated to ensuring customers have an adequate supply of the vaccines they need when they need them,” said Stacy Kearney Bucha, General Manager of VaxServe. “We’re committed to helping them achieve their desired health outcomes with tools that make their business processes more efficient.”
To ensure a ready supply, the company offers access to products as well as contract fulfillment across most vaccine manufacturers so customers can purchase all vaccines from one place. Rounding out VaxServe’s offering is a roster of customized workflow solutions intended to boost program efficiencies in the areas of operations, data and analytics, and immunization advocacy.
Many large customers (retail pharmacies, health systems, employer groups, and the like) benefit from streamlining areas of their immunization business such as forecasting, ordering and shipping. With the help of meaningful analytics and insights, they can fine-tune their programs to be more efficient, thus saving time, resources and costs.
To illustrate, VaxServe supported a longstanding large, regional customer through the execution of its national growth strategy. Early on, VaxServe’s analytics team worked with the customer to generate data insights into behaviors at each site, and then provided program design and training assistance.
Moving into the next phase of the partnership that will focus on vaccine procurement, VaxServe expects to bring even greater efficiencies to the customer’s business.
Our unique position in the U.S. as the only distributor owned by a vaccine manufacturer allows us to deliver exceptional clinical expertise and seamless operational integration to our valued customers
The company has long recognized that a one-size-fits-all doesn’t always work. Although some approaches are universal, others should be modified to align with a customer’s preferred tools and practices. In such cases, VaxServe works to integrate within preferred systems.
While VaxServe’s immunization services and solutions model may start with the customer, it certainly doesn’t end there. The company’s customer-centric approach is in tune on a broader scale with emerging public health trends and a changing industry landscape.
For example, over the past few years, what has traditionally been known as “flu season” has evolved into “respiratory season.” Along with seasonal influenza, COVID-19 and respiratory syncytial virus (RSV) infection rates are on the rise during the fall and winter months.
This dynamic has underscored the need for healthcare immunizers to adapt and adjust their immunization programming to best serve patients during high demand periods. As a result, customers have come to rely on VaxServe to ensure a more robust vaccine supply as well as help achieve efficient program operations.
Sometimes, industry changes call for new ways of reaching people who may not access health information through traditional channels. To address the gap, VaxServe partners with customers to explore new pathways that connect communities and individuals with vital information about the importance of vaccination.
This firm commitment to public health traces back to the company’s early efforts to bring meningococcal vaccines to college campuses and years later, helping to pioneer the concept of pharmacy-based vaccine clinics.
In today’s competitive market, VaxServe is much more than a distributor; it is a public health champion and preferred partner widely recognized for delivering clinical expertise and operational integration on behalf of its valued customers. A subsidiary of Sanofi, the company offers a blend of customizable solutions, exceptional service, and an uncompromising dedication to improving public health through vaccination.
VaxServe is in a unique position in the U.S. market, according to Bucha. “We are the only distributor in the country owned by a vaccine manufacturer, which allows us to deliver exceptional clinical expertise and seamless operational integration to our valued customers.”


